Posts tagged Alcohol Use Disorder
Sobrera Pharma receives patent approval in the USA
Sobrera Pharma receives patent approval in the USA

Sobrera Pharma AB, a Swedish pharmaceutical company developing new therapies for Alcohol Use Disorder (AUD), announces that the United States Patent and Trademark Office (USPTO) has granted a new patent US 11,318,143 further strengthening the Company’s Intellectual property position and coverage for the Company’s therapeutic drug candidate SO-001.

Read More
PressreleaseMelisha LinnellSobrera Pharma AB, life science, Alcohol Use Disorder, GU Ventures, holdingbolaget vid göteborgs universitet
Sobrera Pharma receives patent approval in Europe
Sobrera Pharma receives patent approval in Europe

Sobrera Pharma AB is pleased to announce the Decisions to Grant on the European patent 3582764 titled ’Treatment of Alcohol Use’ by the European Patent Office (EPO). The decision to grant on the patent provides a protection of our drug candidate SO-001 for use in treating alcohol use disorder (AUD) and/or treating alcohol risk consumption.

Read More
PressreleaseMelisha LinnellLife Science, addiction, European Patent Office, Alcohol Use Disorder, Ann Charlotte Rosendahl, Sobrera Pharma AB, European patent, Treatment of Alcohol Use, substance use disorders